Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS

  • Read more about MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS
Patent Cooperation Treaty
PCT/US2009/035470
Filed on 2009-02-27

Methods and Compositions for the Diagnosis And Treatment of Esophageal Adenocarcinomas

  • Read more about Methods and Compositions for the Diagnosis And Treatment of Esophageal Adenocarcinomas
US Application 12/682,318
Filed on 2010-07-07

MiRNA Biomarkers Predict Esophageal Carcinoma Diagnosis And Barrett's Esophagus Status

  • Read more about MiRNA Biomarkers Predict Esophageal Carcinoma Diagnosis And Barrett's Esophagus Status
Japan
2010-529072
Filed on 2008-10-10

Therapies Using Zanolimumab To Enhance The Immune Response

  • Read more about Therapies Using Zanolimumab To Enhance The Immune Response
Patent Cooperation Treaty
PCT/US11/034066
Filed on 2011-04-27

Methods Of Obtaining Antigen-Specific T Cell Populations

  • Read more about Methods Of Obtaining Antigen-Specific T Cell Populations
Australia
2009214980
Filed on 2009-02-10

Methods Of Obtaining Antigen-Specific T-cell Populations

  • Read more about Methods Of Obtaining Antigen-Specific T-cell Populations
US Patent 8,759,014
Filed on 2010-08-17

Methods of Obtaining Antigen-Specific T Cell Populations

  • Read more about Methods of Obtaining Antigen-Specific T Cell Populations
European Patent
09710958.1
Filed on 2009-02-10

Antiangiogenic Small Molecules and Methods of Use

  • Read more about Antiangiogenic Small Molecules and Methods of Use
Patent Cooperation Treaty
PCT/US2010/043998
Filed on 2010-07-30

MiRNA Biomarkers Predict Esophageal Carcinoma Diagnosis And Barrett's Esophagus Status

  • Read more about MiRNA Biomarkers Predict Esophageal Carcinoma Diagnosis And Barrett's Esophagus Status
China
200880116343.7
Filed on 2008-10-10

Methods and Compositions For the Delivery of Vaccines to Disrupted Epithelium

  • Read more about Methods and Compositions For the Delivery of Vaccines to Disrupted Epithelium
US Application 12/863,572
Filed on 2010-10-13

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 799
  • Page 800
  • Page 801
  • Page 802
  • Page 803
  • Page 804
  • Page 805
  • Page 806
  • Page 807
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health